Regencell Bioscience Lim... (RGC)

AI Score

Unlock

29.12

1.87 (6.86%)

At close: Apr 17, 2025, 3:59 PM

28.62

-1.70%

After-hours: Apr 17, 2025, 07:37 PM EDT

Regencell Bioscience Balance Sheet Statement

Financials in USD. Fiscal year is July - June.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q1 2020	Q2 2018	Q1 2018	Q4 2017	Q3 2017	Q2 2017	Q1 2017	Q4 2016	Q3 2016	Q2 2016	Q1 2016
Period Ending	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Sep 30, 2019	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016	Dec 31, 2015	Sep 30, 2015
Cash & Equivalents	2.96M	2.96M	4.8M	4.8M	1.56M	1.56M	n/a	n/a	6.42M	6.42M	n/a	n/a	59.41K	59.41K	305.96K	305.96K	386.98K	386.98K	-243.31K	228.8M	189.5M	235.5M	408.8M	246.5M	186.9M	288.1M	328M	219.6M	99.6M
Short-Term Investments	5M	5M	n/a	n/a	10M	10M	n/a	n/a	10M	10M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	486.61K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	97.68K	97.68K	642.42K	642.42K	108.5K	108.5K	1.36M	1.36M	114.3K	114.3K	2.05M	2.05M	191.42K	191.42K	184.16K	184.16K	18.72K	18.72K	-243.31K	422.5M	409.4M	398.3M	377.3M	379.4M	374.3M	360.3M	349.2M	373.8M	365.5M
Receivables	152.78K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	184M	73.1M	95.1M	52.9M	155.1M	45M	56.1M	46.7M	153.1M	48.8M
Inventory	n/a	n/a	n/a	n/a	-56.55K	n/a	n/a	n/a	-27.6K	n/a	n/a	n/a	-7.44K	n/a	n/a	n/a	n/a	n/a	n/a	22.9M	23.9M	24.4M	23.3M	20.9M	20.5M	22.6M	22.8M	22.4M	19.5M
Other Current Assets	n/a	-0.00	5.03M	5.03M	56.55K	56.55K	14.19M	14.19M	0.00	0.00	19.01M	19.01M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	27.6M	32.5M	31.5M	29.3M	24.4M	30.4M	30.3M	28.2M	43.1M	44.1M
Total Current Assets	8.11M	8.11M	9.83M	9.83M	11.62M	11.62M	14.19M	14.19M	16.44M	16.44M	19.01M	19.01M	66.85K	66.85K	305.96K	305.96K	386.98K	386.98K	243.31K	463.3M	319M	386.5M	514.3M	446.9M	282.8M	397.1M	425.7M	438.2M	212M
Property-Plant & Equipment	226.51K	226.51K	n/a	n/a	891.91K	891.91K	n/a	n/a	1.46M	1.46M	n/a	n/a	81.86K	81.86K	110.26K	110.26K	108.32K	108.32K	n/a	1.51B	1.5B	1.5B	1.36B	1.39B	1.38B	1.37B	1.37B	1.4B	1.4B
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	389.4M	390.4M	400.8M	372.1M	373M	375.7M	376.8M	377.7M	378.9M	379.8M
Total Long-Term Assets	324.2K	324.2K	642.42K	642.42K	1M	1M	1.36M	1.36M	1.57M	1.57M	2.05M	2.05M	273.29K	273.29K	294.42K	294.42K	127.04K	127.04K	-243.31K	2.38B	2.35B	2.36B	2.17B	2.2B	2.19B	2.18B	2.17B	2.19B	2.2B
Total Assets	8.44M	8.44M	10.48M	10.48M	12.62M	12.62M	15.55M	15.55M	18.02M	18.02M	21.06M	21.06M	340.13K	340.13K	600.37K	600.37K	514.02K	514.02K	n/a	2.84B	2.67B	2.75B	2.69B	2.65B	2.48B	2.57B	2.59B	2.63B	2.41B
Account Payables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	232.2M	122.4M	122.3M	177.3M	194.8M	101.5M	184.2M	167M	229.7M	102M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	186.2M	150.2M	184.6M	207.3M	192.7M	156.9M	194.7M	224M	203.4M	144.8M
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.36K	1.36M	3.68M	3.68M	3.54M	3.54M	3.07M	3.07M	n/a	26.6M	26.7M	26.8M	25.4M	25.5M	25.1M	26M	25.7M	27.4M	27M
Other Current Liabilities	n/a	8.44K	n/a	n/a	n/a	10.57K	n/a	n/a	n/a	15.65K	-1.36K	n/a	n/a	82.81K	n/a	0.00	n/a	n/a	n/a	116.4M	78.8M	101M	111.9M	97M	88.3M	78.3M	92.4M	90.8M	72M
Total Current Liabilities	193.58K	193.58K	n/a	n/a	606.91K	606.91K	n/a	n/a	577.76K	577.76K	1.36K	1.36M	4.34M	4.34M	3.59M	3.59M	3.16M	3.16M	n/a	561.4M	378.1M	434.7M	521.9M	510M	371.8M	483.2M	509.1M	551.3M	345.8M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	2.34B	2.34B	2.34B	2.2B	2.2B	2.2B	2.2B	2.2B	2.23B	2.23B
Other Long-Term Liabilities	n/a	n/a	n/a	312.55K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	393.3M	399M	393.6M	379.4M	365.2M	355.2M	345.5M	337.6M	315.1M	315.2M
Total Long-Term Liabilities	25.93K	25.93K	312.55K	312.55K	25.41K	25.41K	873.79K	n/a	360.27K	360.27K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	3.14B	3.15B	3.15B	2.99B	2.97B	2.97B	2.96B	2.96B	2.96B	2.97B
Total Liabilities	219.51K	219.51K	312.55K	312.55K	632.32K	632.32K	873.79K	n/a	938.03K	938.03K	1.36M	1.36M	4.34M	4.34M	3.59M	3.59M	3.16M	3.16M	n/a	3.7B	3.53B	3.58B	3.51B	3.48B	3.34B	3.45B	3.46B	3.51B	3.31B
Total Debt	85.74K	85.74K	n/a	n/a	463.67K	25.41K	n/a	n/a	771.25K	360.27K	1.36K	1.36M	3.68M	3.68M	3.54M	3.54M	3.07M	3.07M	n/a	2.37B	2.37B	2.37B	2.22B	2.22B	2.22B	2.22B	2.22B	2.26B	2.26B
Common Stock	130.00	130.00	10.16M	10.16M	130.00	130.00	14.67K	14.67M	130.00	130.00	19.7K	19.7M	100.00	100.00	100.00	100.00	100.00	100.00	n/a	100K	100K	100K	100K	100K	100K	100K	100K	100K	100K
Retained Earnings	-21.62M	-21.62M	n/a	n/a	-17.32M	-17.32M	n/a	n/a	-11.44M	-11.44M	n/a	n/a	-4M	-4M	-2.99M	-2.99M	-2.65M	-2.65M	n/a	70.9M	76.1M	99.2M	110.3M	96.5M	77.4M	69.5M	70.4M	64.2M	43.5M
Comprehensive Income	-45.77K	-45.77K	n/a	n/a	-86.66K	-86.66K	n/a	n/a	0.00	0.00	n/a	n/a	n/a	n/a	-22.85K	n/a	-9.52K	n/a	-1.84M	-2.24B	-2.27B	-2.24B	-2.19B	-2.15B	-2.14B	-2.09B	-2.04B	-2B	-1.96B
Shareholders Equity	8.22M	8.22M	10.16M	10.16M	12.03M	12.03M	14.66M	14.67M	17.07M	17.07M	19.7M	19.7M	-4M	-4M	-2.98M	-2.98M	-2.65M	-2.65M	-1.84M	-855.9M	-855.3M	-835.1M	-826.3M	-839.1M	-861.7M	-872.4M	-873.7M	-877.8M	-902.2M
Total Investments	5M	5M	n/a	n/a	10M	10M	n/a	n/a	10M	10M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	486.61K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a